or
forgot password
  • cancer clinical trials in durham, NC

  • Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Colorectal Cancer, Metastatic Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia
    Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Lung Cancer
    Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    Duke University Medical Center (Pediatric Site)
    Durham, North Carolina 27710
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers.
    Duke University Medical Center
    Durham, North Carolina 27710
    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome, Systemic Mastocytosis
    Scleroderma: Cyclophosphamide or Transplantation (SCOT)
    Duke University
    Durham, North Carolina 27710
    Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
    Duke Children's Hospital and Health Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Doxorubicin, Cyclophosphamide, and/or Paclitaxel in Treating Women With Nonmetastatic Breast Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Breast Cancer
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA Medical Center, Durham
    Durham, North Carolina 27705
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Radiation Therapy in Treating Young Patients With Gliomas
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain Tumor, Central Nervous System Tumor
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Fallopian Tube Cancer, Ovarian Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    ABT-510 and Bevacizumab in Treating Patients With Advanced Solid Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Unspecified Adult Solid Tumor, Protocol Specific
    Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Unspecified Adult Solid Tumor, Protocol Specific
    Enzastaurin Versus Lomustine in Glioblastoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Glioblastoma
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    Duke University Medical Center
    Durham, North Carolina 27710
    Melanoma
    Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
    Duke University Medical Center
    Durham, North Carolina 27710
    Endometrial Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Leiomyoma
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Duke University Medical Center
    Durham, North Carolina 27710
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Duke University Medical Center
    Durham, North Carolina 27710
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Breast Neoplasms
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Durham Veterans Affairs Medical Center
    Durham, North Carolina 27705
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Fludarabine-based Conditioning for Severe Aplastic Anemia
    Duke University Medical Center
    Durham, North Carolina 27710
    Anemia, Aplastic
    Comparison of Rituxan Versus Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (ASCT)
    Duke University Medical Center
    Durham, North Carolina 27710
    Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Prostate Cancer
    PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Non Hodgkin Lymphoma
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Duke Cancer Institute
    Durham, North Carolina 27710
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Duke University Medical Center
    Durham, North Carolina 27710
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Duke University Medical Center
    Durham, North Carolina 27710
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Duke University Medical Center
    Durham, North Carolina 27710
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
    Duke University Medical Center
    Durham, North Carolina 27710
    Glioblastoma Multiforme
    Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
    Duke University Medical Center
    Durham, North Carolina 27710
    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
    Duke University Medical Center
    Durham, North Carolina 27710
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, NK Cell Lymphoblastic Leukemia
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    Duke University
    Durham, North Carolina 27710
    Mycoses, Candidiasis, Invasive, Candidemia
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Esophageal Neoplasms, Stomach Neoplasms, Neoplasm Metastasis
    Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
    Celldex Investigational Site
    Durham, North Carolina 27710
    Malignant Glioma
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Duke Cancer Institute
    Durham, North Carolina 27710
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Phase 1-2 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
    Duke University Medical Center
    Durham, North Carolina 27710
    Pheochromocytoma, Paraganglioma
    Bicalutamide in Treating Patients With Metastatic Breast Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Breast Cancer
    Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Breast Cancer
    Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
    Duke University
    Durham, North Carolina 27710
    Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Neuroblastoma
    Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
    Duke Cancer Institute
    Durham, North Carolina 27710
    Endometrial Cancer, Precancerous Condition
    Sorafenib in Myelodysplastic Syndrome
    Duke University Medical Center
    Durham, North Carolina 27710
    Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
    Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Lymphoma, Follicular
    Adult Double Cord Blood Transplant Study
    Duke University Medical Center
    Durham, North Carolina 27710
    Cord Blood Stem Cell Transplantation, Hematologic Malignancies
    Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Multiple Myeloma and Plasma Cell Neoplasm